project id: TCGA-ACC; case submitter id: TCGA-OR-A5LJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.9; age at index: 54; days to birth: -20069; days to death: 1105; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1951; year of death: 2008; age at diagnosis: 20069; ajcc clinical m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2633; initial weight: 110.0; sample id: 6dd9dd3b-f1ff-4ade-b7b0-2ff7aca52ca8; sample submitter id: TCGA-OR-A5LJ-01A; portion id: 95172587-b85f-46dc-a8fc-523e80824793; portion submitter id: TCGA-OR-A5LJ-01A-11; slide id: 74cf9ac7-9bcd-455b-8270-a5d0d739f282; slide submitter id: TCGA-OR-A5LJ-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 98.0; section location: TOP;